This database contains 8 studies, archived under the term: "neuropsychiatric symptoms"
Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer’s disease: A randomized, double-blind, sham-controlled trial
Suemoto, Claudia Kimie,
Apolinario, Daniel,
Nakamura-Palacios, Ester Miyuki,
Lopes, Leonardo,
Paraizo Leite, Renata Elaine,
Sales, Manuela Castro,
Nitrini, Ricardo,
Brucki, Sonia Maria,
Morillo, Lilian Shafirovitz,
Magaldi, Regina Miksian,
Fregni, Felipe
Background: Apathy is the most common neuropsychiatric symptom in Alzheimer’s disease (AD) and it is associated with changes in prefrontal neural circuits involved with generation of voluntary actions. To date no effective treatment for apathy has been demonstrated. Objective: We aimed to investigate the effects and safety of repetitive transcranial direct current stimulation (tDCS) on […]
The effect of person-centred dementia care to prevent agitation and other neuropsychiatric symptoms and enhance quality of life in nursing home patients: A 10-month randomized controlled trial
Rokstad, Anne Marie Mork,
Røsvik, Janne,
Kirkevold, Øyvind,
Selbaek, Geir,
Saltyte Benth, Jurate,
Engedal, Knut
Aims: We examined whether Dementia Care Mapping (DCM) or the VIPS practice model (VPM [Valuing people with dementia and those who care for them (V); treating people as Individuals (I); looking at the world from the Perspective of the person with dementia (P); and a positive Social environment in which the person living with dementia […]
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial
Freund-Levi, Yvonne,
Jedenius, Erik,
Tysen-Bäckström, Ann Christine,
Lärksäter, Marie,
Wahlund, Lars-Olof,
Eriksdotter, Maria
Objective: To examine the effects of galantamine and risperidone on neuropsychiatric symptoms in dementia (NPSD) and global function.; Methods: Using a randomized, controlled and open-blind, one-center trial at an in- and outpatient clinic at a university hospital, we studied 100 adults with probable dementia and NPSD. Participants received galantamine (N = 50, target dose 24 mg) […]